FDA Grants Orphan Drug Designation to OM-301 for Multiple Myeloma
https://pixabay.com/en/thumbs-up-okay-good-well-done-2056022/

FDA Grants Orphan Drug Designation to OM-301 for Multiple Myeloma

  Have you ever heard of the Orphan Drug Act? This Act helped stimulate and advance the development of, and research into, therapeutics for individuals living with rare or underserved conditions. In…

Continue Reading FDA Grants Orphan Drug Designation to OM-301 for Multiple Myeloma
$6.75 Million in Grants Sets the Stage for the Next Level of Blood Cancer Treatments
source: pixabay.com

$6.75 Million in Grants Sets the Stage for the Next Level of Blood Cancer Treatments

  After forty years of research to counter or cure acute myeloid leukemia and other blood cancers, a few years ago the medical community exploded with eight new cancer drugs.…

Continue Reading $6.75 Million in Grants Sets the Stage for the Next Level of Blood Cancer Treatments